Patents by Inventor Andras Bilkei-Gorzo

Andras Bilkei-Gorzo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same and a process for the preparation of the novel compounds
    Patent number: 6130215
    Abstract: The invention refers to novel piperazinylalkylthiopyrimidine derivatives of formula (I) being suitable for the treatment of diseases due to pathological alterations of the central nervous system, pharmaceutical compositions containing the above derivatives, and a process for the preparation of the novel compounds.
    Type: Grant
    Filed: June 23, 1998
    Date of Patent: October 10, 2000
    Assignee: Egis Gyoyszergyar RT
    Inventors: Ivan Jakoczi, Daniel Bozsing, Ildiko Ratz nee Simonek, Istvan Gacsalyi, Gabor Szenasi, Eva Schmidt, Aniko Miklos nee Kovacs, Andras Bilkei-Gorzo, Gabor Blasko, Istvan Gyertyan, Gabor Nemeth, Gyula Simig, Karoly Tihanyi, Andras Egyed
  • 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivatives as anxiolytic agents having enhanced receptor specificity
    Patent number: 6093747
    Abstract: The new compound of Formula (I) and salts thereof possess valuable anxiolytic properties.
    Type: Grant
    Filed: June 14, 1999
    Date of Patent: July 25, 2000
    Assignee: Egis Gyogyszergyar RT.
    Inventors: Istvan Gacsalyi, Imre Klebovich, Zoltan Budai, Gyula Lukacs, Erzsebet Kaufmanne Bojti, Eva Schmidt, Istvan Gyertyan, Andras Bilkei Gorzo, Gabor Blasko, Miklos Abermann, Katalin Baloghne Nemes, Gyula Grezal, Andras Egyed
  • 1-?2-(substituted vinyl)!-5H-2,3-benzodiazepine derivatives
    Patent number: 5942506
    Abstract: This invention relates to new 1-?2-(substituted vinyl)!-5H-2,3-benzodiazepine derivatives, a process for the preparation thereof, pharmaceutical compositions comprising the same, to the use of the said benzodiazepine derivatives for the treatment of diseases and for the preparation of pharmaceutical compositions suitable for the treatment of diseases. The compounds according to the invention correspond to the general formula (I), ##STR1## wherein the variables are herein below defined, and the compounds possess central nervous activities.
    Type: Grant
    Filed: February 9, 1996
    Date of Patent: August 24, 1999
    Assignee: GIS Gyogyszergyar Rt.
    Inventors: Pal Vago, Jozsef Reiter, Istvan Gyertyan, Istvan Gacsalyi, Andras Bilkei-Gorzo, Andras Egyed, Ferenc Andrasi, Anna Bakonyi, Pal Berzsenyi, Hilda Botka, Tamas Hamori, Cecilia Salamon Haskane, Edit Horvath, Katalin Horvath, Peter Korosi, Gyorgyne Mate, Imre Moravcsik, Eszter Szentkuti, Gabor Zolyomi, Gabor Blasko, Klara Daroczi Kazone, Gyula Simig, Karoly Tihanyi, Judit Bajnogel
  • Heterocyclic compounds, pharmaceutical compositions comprising them and process for the preparation thereof
    Patent number: 5889018
    Abstract: The invention relates to anxiolytic pharmaceutical compositions comprising as active ingredient 1-sytrylisoquinoline derivatives of general formula (I), whereinn is 1, 2, 3 or 4;R may be the same or different and represent(s) hydrogen, lower alkyl, lower alkoxy or hydroxy, or two substituents R attached to adjacent carbon atoms may form together an alkylenedioxy group;R.sup.1 represents hydrogen or lower alkyl, andAr stands for an optionally substituted aryl or heteroaryl,Some of the compounds of general formula (I) is known, but the majority thereof has not so far described in the literature.The invention also encompasses the preparation of the new compounds of general formula (I), which comprises reacting a compound of general formula (II) with an aldehyde or general formula (III) in the presence of a condensing agent or an acidic catalyst.
    Type: Grant
    Filed: May 3, 1995
    Date of Patent: March 30, 1999
    Assignee: Egis Gyogyszergyar RT.
    Inventors: Gyula Balogh, deceased, Imre Doman, Gabor Blasko, Gyula Simig, Erzsebet Kovacs nee Kaszab, Istvan Gyertyan, Andras Egyed, Istvan Gacsalyi, Andras Bilkei-Gorzo, Katalin Pallagi, Katalin Szemeredi, Klara Kazo nee Daroczi
  • Triazole substituted quinoline derivatives for gastrointestinal treat-treatment
    Patent number: 5830903
    Abstract: The invention relates to pharmaceutical compositions for the treatment or prevention of lesions of gastrointestinal mucous membranes and having secretion inhibiting, cytoprotective activities. The compositions contain in a biologically effective quantity a triazole-group-substituted quinoline derivative of general formula (I)R.sup.1 stands for a 1-triazolyl-group in position 2 or 4 ora 3-triazolyl-thio ora 5-/C.sub.1-4 -alkyl/-3-triazolyl-thio-group,R.sup.2 stands for a hydrogen atom in position 3 or optionally in position 2, or for a C.sub.1-4 -alkyl-group,R.sup.3 stands for a hydrogen atom or for a C.sub.1-4 -alkyl-group,X stands for a hydrogen or halogen-atom or for a C.sub.1-4 -alkyl-group or its salts. The invention includes processes for the preparation of the above compositions, and methods for treatment of patients in need of such treatment by administering the substance or the composition. The prefered substance of formula (IV) is also subject of the invention.
    Type: Grant
    Filed: January 29, 1996
    Date of Patent: November 3, 1998
    Assignee: Alkaloida Chemical Co., Ltd.
    Inventors: Laszlo Frank, Klara Gyires, Andras Bilkei-Gorzo, Ferenc Korodi, Vilmos Galamb